Current projects
Evaluation of the implementation of the UK AMR Strategy
Evaluation of the implementation of the UK AMR Strategy

PIRU has been commissioned to undertake an evaluation of the UK Anti-Microbial Resistance (AMR) Strategy, 2013-18. The Strategy is very broad, containing many potentially interacting actions across many sectors, including human and animal health, and with an international dimension. A conventional evaluation of the impact of the Strategy, as would be appropriate to a single intervention, is not possible. Instead, the evaluation will comprise a study of the implementation of the Strategy and the key mechanisms of change identified in the Strategy, with a view to helping strengthen the Strategy in future.

The first stage of the evaluation, a scoping study, is now complete. The purpose of the scoping study was to improve our understanding of the content of the Strategy and the processes of implementation – an important first step in designing an evaluation of the Strategy.

PIRU is working in partnership with Katharina Staerk and team at the Royal Veterinary College on the evaluation.

Please contact for further details of this project.

The scoping study included interviews with a small number of people involved in the development and delivery of the Strategy at central government level, rapid reviews of evidence underpinning each action in the Strategy, and development of a logic model (a diagram showing how actions in the Strategy may lead to the ultimate goals of the Strategy).

Following the scoping study, we identified the areas of the Strategy and research questions that we would include in the main evaluation. The main evaluation consists of the following elements:

  • Evaluating the national and local implementation of the Strategy
  • Synthesis of evidence underpinning:
    • Use of surveillance systems in an infectious disease context
    • Use of diagnostic tests for infectious/communicable conditions in a secondary care setting
    • Use of diagnostic point of care tests in primary care
    • Implementation of 'prudent use' principles in veterinary medicine
  • Use of data to effect change in behaviour
  • Anti-microbial resistance and the food chain
  • Innovation challenges in the biopharma industry
  • Strengthening international collaboration
  • The role of patients and the public in implementation of the Strategy
  • Challenge to, and validation of, findings

The elements are designed to fit together and provide a coherent account of the implementation of the Strategy. Working with the Royal Veterinary College, PIRU will complete the evaluation by December 2018.

Reports from the evaluation are due to be published in spring 2020.